1. The Prevalence and Effects of Cannabis Use Among Individuals With Schizophrenia and Related Psychotic Disorders
- Author
-
Ana Fresán, Carlos-Alfonso Tovilla-Zarate, and Rebeca Robles-García
- Subjects
education.field_of_study ,Psychosis ,medicine.medical_specialty ,biology ,Aggression ,Population ,Cognition ,biology.organism_classification ,medicine.disease ,030227 psychiatry ,03 medical and health sciences ,0302 clinical medicine ,Epidemiology ,medicine ,Cannabis ,medicine.symptom ,education ,Psychiatry ,Psychology ,Psychosocial ,030217 neurology & neurosurgery ,Effects of cannabis ,Clinical psychology - Abstract
Epidemiological and clinical evidence indicates that cannabis is the illicit drug most widely used by individuals with psychotic disorders. There is a need to understand the reasons for the increase in the rate of cannabis use in this population, as several lines of research report that cannabis use has negative effects on the clinical course of their illnesses as well as in psychosocial functioning. In terms of clinical effects, those with psychotic disorders who use cannabis may have more severe psychotic symptoms, more prominent cognitive deficits, poorer adherence to antipsychotic treatment, and more frequent clinical relapses. Regarding psychosocial effects, they may experience rejection, stigma, global dysfunction, aggression, and increased suicide risk. There is a need for preventive strategies to encourage persons with psychosis to discontinue or reduce cannabis use in order to mitigate its negative effects on treatment and functional recovery.
- Published
- 2018
- Full Text
- View/download PDF